MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Physician’s Prescription: Patients must obtain a prescription from a qualified physician registered with the TCUP.

Law 52

Law Dispensary Clinical Trials Programs 52

CannaMD

MAY 25, 2021

In recent years, research has revealed that two of marijuana’s two major cannabinoids — THC and CBD — can interact with the human endocannabinoid system to influence bone healing and regeneration. At the four week mark and beyond, however, this trend reversed, resulting in an increase in new bone development.

Marijuana 111

Marijuana Research and Development Clinical Trials THC 111

PrestoDoctor

SEPTEMBER 15, 2023

Obsessive-Compulsive Disorder (OCD) is a debilitating mental health condition that is characterized by intrusive thoughts and compulsive behaviors. However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. These obsessions can vary greatly from person to person.

Research and Development 105

Research and Development Therapy Treatment Strains 105

Cannabis Law Report

JANUARY 4, 2022

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, has named Simon Allen as Chief Executive Officer and a member of the company’s Board of Directors, effective February 1 st , 2022. and Australia.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

More than half the states in the country have now legalized medical cannabis for patients with qualifying conditions and several more have gone so far as to legalize recreational marijuana for adults. GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Lennox-Gestaut Syndrome.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

DECEMBER 11, 2021

These clinics offer patients two types of medical cannabis: oil extracted from the seeds, and traditional cannabis remedies that use various parts of the plant including the leaves, roots or flowers. Department records show that the health condition of 74% of patients improves after such treatment. The first is Daycha Oil.

Oil 52

Oil Blood Pressure Concentrates Patients 52

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders.

History 119

History Microdosing Research and Development Clinical Trials 119

Veriheal

AUGUST 31, 2020

Choosing only 10 winners for the $10,000 in scholarships among the strong applications we received from multiple disciplines and concentrations in higher education—from students of all backgrounds and interests—was extremely difficult. Essay: “Integrating Research and Medicine: Cannabis Related Treatment for Neurodegenerative Diseases”.

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaTech

MARCH 24, 2019

Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. Despite the prevalence of these often painful and incurable disorders, funding for research is limited. Recently there has been a surge of interest and funding for women’s health-related research.

Research and Development 45

Research and Development Therapy Clinical Trials Chronic Pain 45

CannaMD

AUGUST 26, 2020

As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Exploring alternative therapies, researchers turned their attention to marijuana cannabinoid, cannabidiol – more commonly referred to as CBD. Conditioned place preference. Current Cocaine Treatments. mice/rats).

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

NOVEMBER 29, 2019

This explains why THC affects thinking, pleasure, memory, concentration, sensory, time perception, movements, and coordination. For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. That’s why some people choose THC oil. THC Oil Benefits. THC Oil Effects.

Oil 104

Oil THC Cannabinoids Research and Development 104

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

The Cannigma

JUNE 24, 2021

While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. By interacting with the receptors of the ECS, cannabis modulates the bodily functions that cause or exacerbate health conditions.

CBD 75

CBD Microdosing Edibles Sleep 75

Cannabis Law Report

JULY 28, 2021

The results also provide confidence in the Company’s plan to dedicate resources to advance PD-001 through FDA IND-enabling studies to support Phase 1 and 2 clinical studies. . – July 28, 2021) – PharmaDrug Inc.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

JANUARY 11, 2019

However, we firmly disagree that the referenced clinical trials are in fact “substantial,” as the trials were extremely limited in scope, and funding and the publication of these trials were limited. There is no signal for the development of substance use disorder in individuals consuming CBD-containing products.”. “It

Hemp 49

Hemp CBD Law Seed-To-Sale 49

Project CBD

OCTOBER 26, 2023

The vast majority of the existing research is on how specific cannabinoids kill cancer, but a growing body of work is revealing how the entourage of compounds found in whole-plant cannabis kills cancer. Without increased blood flow, the tumor does not have enough nutrition to sustain its development.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

DECEMBER 20, 2021

Rule 154 6 of Drugs & Cosmetics Rules, 1945 states that- subject to the conditions of rule 157 being fulfilled, a licence to manufacture for sale any Ayurvedic (including Siddha) or Unani drugs shall be issued in Form 25D. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

NOVEMBER 12, 2021

Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction, today announced financial results for the first quarter of its fiscal year ending June 30, 2022 and reported recent business highlights. .”

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Veriheal

JANUARY 28, 2022

The developmental condition can be difficult to manage in severe cases, putting the individual and their family members under a great deal of stress. A team of researchers at Tel Aviv University in Tel Aviv, Israel, led by Ph.D. The researchers were able to alleviate the symptoms of autism in animal models using THC-rich cannabis oil.

Oil 99

Oil THC Research and Development Treatment 99

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1: Bionorica SE BX-1 is an oral solution containing dronabinol, being developed by Bionorica. Dronabinol is a synthetic form of ??-THC,

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Peninsula Alternative Health

MAY 15, 2019

As medical cannabis emerges from the dark days of prohibition, researchers are finding a wide range of conditions responding successfully to it. clinical research is extremely difficult to conduct. Epilepsy Seizure disorders are on the list of qualifying conditions for most medical cannabis states.

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

FloridaMarijuana.net

OCTOBER 19, 2018

Depression can be situational, but Clinical Depression, which comes and goes and/or lasts for more than a few days, is a chemical imbalance within the central nervous system. Decreased energy, fatigue, feeling “slowed down” Difficulty concentrating, remembering, making decisions.

Marijuana 189

Marijuana Research and Development Patients Clinical Trials 189

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1 is an oral solution containing dronabinol, being developed by Bionorica. THX-110 is a being developed by Therapix Biosciences.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

CannaMD

MARCH 8, 2020

Researchers summarized five key points from the 2020 review : * We estimate that more than 2 million U.S. Few randomized clinical trials have been conducted or are planned to explore the effects of marijuana on cardiovascular risk. Instead, the study can be seen as a starting point for discussion and further study. Arrhythmia.

Patients 79

Patients Marijuana Research and Development Clinical Trials 79

Kind Meds (Cannabis Education Blog)

DECEMBER 6, 2018

This drastically limits the research opportunities and funding available for cannabis studies. Most cannabis research studies and clinical trials in recent years required researchers to administer THC doses orally in pill form. Poor concentration. Stress relief. Mood swings. Muscle and joint pain.

Indica 71

Indica Sativa Strains Hybrid 71

Alchimia

JANUARY 25, 2022

While this research is certainly worth celebrating, the reality behind the message can be easily misunderstood in this age of social media. It seems that every time a positive clinical study relating to cannabis and COVID comes out, the world gets excited about the medical potential of weed as a miracle medicine to end the pandemic.

Research and Development 98

Research and Development Terpenes CBD Treatment 98

Green Relief

MAY 13, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology. But the U.S.

THC 64

THC CBD Cannabinoids Research and Development 64

Cannabis Law Report

DECEMBER 21, 2019

Joseph Billions writes for Cannabis Law Report……So much work has gone into fully determining the medical applications of cannabis, endless works of research have been conducted on how this gift of nature can help make the world a better place and so far there have been numerous breakthroughs among which is autism treatment.

Research and Development 59

Research and Development CBD Conditions Therapy 59

Cannabis Law Report

NOVEMBER 24, 2021

Published by The Journal of Cannabis Research. Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. The precis is simple. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Green Relief

MAY 12, 2018

The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. Preclinical research and anecdotal accounts indicate that CBD is highly active against brain ischemia, modulating many of the molecular hallmarks of TBI pathology. But the U.S.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. billion by 2024.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Freedom Leaf

JANUARY 10, 2018

We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

JULY 12, 2019

By: James Holley, Molecular Biologist, Scientific Officer, Mike Robinson, Co-founder, Research Institute, and Dr. David Ostrow, M.D., Research Director. International Cannabinoid Cancer Research Institute (Draft 5). Things seemed to go well in animal trials using URB597. (21)

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Cannabis Law Report

OCTOBER 17, 2019

Food and beverage makers are gearing up to sell CBD-containing products, when allowed by regulators, including Lagunitas Brewing, which has developed a cannabis-infused IPA and a THC-based sparkling water, and Ben & Jerry’s, which plans to offer a CBD-infused ice cream. billion in 2025, according to Grandview Research.

Law 40

Law Seed-To-Sale Hemp Recreational 40